PTPN11 and cancer: The most potent compound SHP2‐D26 (Table 1) effectively induced the degradation of SHP2 protein with a DC50 value of 2.6 nM in MV4;11 cells and with Dmax to reduce SHP2 protein levels in cancer cells by more than 95%.